Alan F. Denenberg
Lawyers
Filters
Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SiTime $518 million follow-on offering
The shares are listed on the Nasdaq Global Market
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
SVB Financial $2.25 billion concurrent offerings of notes and preferred stock
The company issued senior notes due 2026 and depositary shares representing Series D and Series E perpetual preferred stock
ForgeRock $316 million IPO
We advised the underwriters on the IPO and NYSE listing
Maravai LifeSciences $1 billion secondary offering
The shares are listed on the Nasdaq Global Select Market
Carvana $750 million notes offering
We advised the initial purchasers on the high-yield debt offering
Intel $5 billion senior notes offering
We advised the underwriters on an investment-grade notes offering
SVB Financial Group $1.25 billion stock offering
We advised the underwriter on the equity offering